OREX

OREX Company Financials

$6.38
*  
0.10
  negative  
1.59%
Get OREX Alerts
*Delayed - data as of Jun. 18, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

 Save stocks for next time


Quarterly Income Statement (values in 000's)

Quarter: Trend 1st 4th 3rd 2nd
Quarter Ending: 3/31/2013 12/31/2012 9/30/2012 6/30/2012
Total Revenue
$857 $857 $857 $857
Cost of Revenue
$0 $0 $0 $0
Gross Profit
$857 $857 $857 $857
Operating Expenses
Research and Development
$15,155 $28,252 $25,806 $12,822
Sales, General and Admin.
$5,100 $5,082 $5,651 $4,742
Non-Recurring Items
$0 $0 $0 $0
Other Operating Items
$0 $0 $0 $0
Operating Income
($19,398) ($32,477) ($30,600) ($16,707)
Add'l income/expense items
$31 $22 $36 $46
Earnings Before Interest and Tax
($19,367) ($32,455) ($30,564) ($16,661)
Interest Expense
$1 $0 $0 $0
Earnings Before Tax
($19,368) ($32,455) ($30,564) ($16,661)
Income Tax
$0 $0 $0 $0
Minority Interest
$0 $0 $0 $0
Equity Earnings/Loss Unconsolidated Subsidiary
$0 $0 $0 $0
Net Income-Cont. Operations
($19,368) ($32,455) ($30,564) ($16,661)
Net Income
($19,368) ($32,455) ($30,564) ($16,661)
Net Income Applicable to Common Shareholders
($19,368) ($32,455) ($30,564) ($16,661)

See also: Company Financials data entry page